Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

19.750
-0.060-0.30%
Volume:2.73M
Turnover:53.80M
Market Cap:52.52B
PE:13.73
High:19.930
Open:19.610
Low:19.440
Close:19.810
52wk High:29.000
52wk Low:12.535
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:1.83
T/O Rate:0.50%
Dividend:0.35
Dividend Rate:1.77%
EPS(LYR):1.439
ROE:6.98%
ROA:1.47%
PB:0.95
PE(LYR):13.73
PS:1.11

Loading ...

Fosun Pharmaceutical Gets Nod for Phase I Trial of Tumor Drug Candidate; Hong Kong Shares Up 5%

MT Newswires Live
·
Mar 06

Hong Kong Market Analysis: Strait Restrictions Eased, Focus on NPC Press Conference

Stock News
·
Mar 05

FOSUN PHARMA Subsidiary Receives Approval for Phase I Clinical Trial of HLX97 in Advanced/Metastatic Solid Tumors

Stock News
·
Mar 05

FOSUN PHARMA (02196) Announces February 2026 Monthly Return with Unchanged Share Capital

Bulletin Express
·
Mar 05

From Following to Leading: FOSUN PHARMA's Global Innovation Journey

Deep News
·
Mar 02

Fosun Pharmaceutical (02196) Announces Poll Results of 2026 EGM and Class Meetings

Bulletin Express
·
Feb 27

Fosun Pharma Gets Regulatory Nod for 6 Billion Yuan Bond Issue

MT Newswires Live
·
Feb 26

FOSUN PHARMA Secures Regulatory Approval for Bond Offering to Professional Investors

Stock News
·
Feb 26

Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China

MT Newswires Live
·
Feb 25

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196.HK, 600196.SH) Receives NMPA Approval for Phase II Clinical Trial of Luvometinib in KRAS-Mutant NSCLC

Bulletin Express
·
Feb 25

Fosun Pharmaceutical Amends Drug Licensing Agreements

MT Newswires Live
·
Feb 25

Fosun Pharma Unit Gets China Acceptance for Anesthesia Drug Application

MT Newswires Live
·
Feb 13

Fosun Pharma (600196) Announces Acceptance of Subsidiary’s New Drug Registration Application

Bulletin Express
·
Feb 13

Fosun Pharma (600196) Announces Acceptance of Subsidiary’s Cisplatin Injection Registration Application

Bulletin Express
·
Feb 13

FOSUN PHARMA's Cisplatin Injection Marketing Application Accepted for Review

Stock News
·
Feb 13

Fosun Pharma Gets Regulatory Approval for Myeloma Drug Trial

MT Newswires Live
·
Feb 13

Fosun Pharma Unit Gets China Acceptance for Application of Local Anaesthetic

MT Newswires Live
·
Feb 10

Fosun Pharma (600196, 02196) Announces Subsidiary’s Tetracaine Hydrochloride Gel Registration Accepted

Bulletin Express
·
Feb 10

Fosun Pharma (600196, 02196) Announces Acceptance of Subsidiary’s Cyclophosphamide Injection Registration

Bulletin Express
·
Feb 05

FOSUN PHARMA's Cyclophosphamide Injection Application Accepted for Review

Stock News
·
Feb 05